SPONSOR
Azienda Ospedaliera Universitaria Integrata Verona
Total Trials
2
Recruiting
2
Phases
Phase 2
Azienda Ospedaliera Universitaria Integrata Verona is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Cystic Fibrosis - Complete, Breast Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Azienda Ospedaliera Universitaria Integrata Verona
How many clinical trials has Azienda Ospedaliera Universitaria Integrata Verona sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Azienda Ospedaliera Universitaria Integrata Verona, of which 2 are actively recruiting participants. These trials cover conditions including Cystic Fibrosis - Complete, Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Azienda Ospedaliera Universitaria Integrata Verona research focus on?
Azienda Ospedaliera Universitaria Integrata Verona clinical trials span Cystic Fibrosis - Complete, Breast Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Azienda Ospedaliera Universitaria Integrata Verona clinical trial?
To participate in a Azienda Ospedaliera Universitaria Integrata Verona trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Azienda Ospedaliera Universitaria Integrata Verona trials with current recruitment status updated daily.
Clinical Trials by Azienda Ospedaliera Universitaria Integrata Verona
NCT07289035 Phase 2
Recruiting
Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.
Cystic Fibrosis - Complete
NCT07071272
Recruiting
Non-inferiority Study of Contrast-enhanced Digital Mammography (CEDM) vs Magnetic Resonance Imaging (MRI) in Terms of Diagnostic Accuracy in Patients Undergoing Preoperative Staging of Established Invasive Breast Cancer
Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology